Financhill
Sell
25

CSTL Quote, Financials, Valuation and Earnings

Last price:
$19.92
Seasonality move :
-1.9%
Day range:
$19.58 - $20.09
52-week range:
$16.97 - $35.84
Dividend yield:
0%
P/E ratio:
32.16x
P/S ratio:
1.74x
P/B ratio:
1.25x
Volume:
203.4K
Avg. volume:
443.6K
1-year change:
-9.98%
Market cap:
$568.6M
Revenue:
$332.1M
EPS (TTM):
$0.62

Earnings Data

Next earnings date for CSTL
May 02
2025
Most recent earnings per share
$0.32
Beat by $0.28
(Feb 27/2025)
Consensus Estimate
$0.04
(Feb 27/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CSTL Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
05/02/2025 Q1 $80.6M -- -- -$0.07 --
02/27/2025 Q4 $83.9M $86.3M $0.32 $0.04 $0.28
11/04/2024 Q3 $79M $85.8M $0.08 $0.01 $0.07
08/05/2024 Q2 $69.4M $87M $0.31 -$0.25 $0.56
05/02/2024 Q1 $66.2M $73M -$0.09 -$0.31 $0.22
02/28/2024 Q4 $61.2M $66.1M -$0.09 -$0.49 $0.40
11/02/2023 Q3 -- -- -$0.26 -$0.73 $0.47
08/02/2023 Q2 -- -- -$0.70 -$0.91 $0.21
05/03/2023 Q1 -- -- -$1.10 -$0.89 -$0.21
02/28/2023 Q4 -- -- -$0.78 -$0.83 $0.05
11/02/2022 Q3 -- -- -$0.77 -$0.97 $0.20
08/08/2022 Q2 -- -- -$0.06 -$0.80 $0.74
05/09/2022 Q1 -- -- -$0.97 -$0.74 -$0.23
02/28/2022 Q4 -- -- -$0.25 -$0.47 $0.22
11/08/2021 Q3 -- -- -$0.47 -$0.37 -$0.10
08/09/2021 Q2 -- -- -$0.35 -$0.39 $0.04
05/10/2021 Q1 -- -- -$0.17 -$0.19 $0.02
03/08/2021 Q4 -- -- -$0.23 -$0.11 -$0.12
11/09/2020 Q3 -- -- -$0.23 -$0.16 -$0.08
08/10/2020 Q2 -- -- -$0.08 -$0.44 $0.36
05/11/2020 Q1 -- -- $0.03 -$0.05 $0.08
03/10/2020 Q4 -- -- $0.11 -$0.02 $0.13
11/11/2019 Q3 -- -- $0.05 -$0.30 $0.35
09/03/2019 Q2 -- -- -$0.15 -$0.47 $0.32
03/31/2019 Q1 -- -- -$0.22 -- --
12/31/2018 Q4 -- -- $0.27 -- --
09/30/2018 Q3 -- -- -$0.42 -- --
06/30/2018 Q2 -- -- -$0.38 -- --
03/31/2018 Q1 -- -- -$0.42 -- --

Castle Biosciences Earnings Questions

  • How Much did Castle Biosciences Generate in Revenue Last Quarter?

    Castle Biosciences reported $86.3M worth of top line sales in its most recent quarter.

  • Did Castle Biosciences Beat Earnings Last Quarter?

    Castle Biosciences announced earnings per share of $0.32 which represents a beat of analyst forecast a $0.04 per share.

  • Is Castle Biosciences Profitable?

    Castle Biosciences reported $70.1M that represents $2.30 per share over the last quarter.

  • What is the Analyst Consensus for Castle Biosciences EPS Next Year?

    Castle Biosciences's earnings are forecast to decrease from $0.62 per share to $0.40 per share next year representing a decrease of -75.63%.

  • When is Castle Biosciences's Earnings Date?

    Castle Biosciences's next earnings date is May 2, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is it Finally Time to Buy Medical Properties Trust?
Is it Finally Time to Buy Medical Properties Trust?

Medical Properties Trust (NYSE:MPW) is a REIT that focuses on…

Why Did Signet Jewelers Stock Go Up So Much?
Why Did Signet Jewelers Stock Go Up So Much?

Signet Jewelers (NYSE:SIG) is the largest diamond retailer in the…

Why Did HealthEquity Stock Fall So Much?
Why Did HealthEquity Stock Fall So Much?

HealthEquity (NASDAQ:HQY) is a fintech company that acts as an…

Stock Ideas

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 36x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Sell
41
Is NVDA Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 37x

Alerts

Buy
78
AJINY alert for Mar 29

Ajinomoto [AJINY] is up 99.61% over the past day.

Buy
85
SLNO alert for Mar 29

Soleno Therapeutics [SLNO] is up 6.8% over the past day.

Buy
69
AGX alert for Mar 29

Argan [AGX] is up 19.83% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock